European Radiology

, Volume 27, Issue 8, pp 3372–3382 | Cite as

Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI

  • Esther E. BronEmail author
  • Marion Smits
  • Janne M. Papma
  • Rebecca M. E. Steketee
  • Rozanna Meijboom
  • Marius de Groot
  • John C. van Swieten
  • Wiro J. Niessen
  • Stefan Klein
Open Access
Computer Applications



To investigate the added diagnostic value of arterial spin labelling (ASL) and diffusion tensor imaging (DTI) to structural MRI for computer-aided classification of Alzheimer's disease (AD), frontotemporal dementia (FTD), and controls.


This retrospective study used MRI data from 24 early-onset AD and 33 early-onset FTD patients and 34 controls (CN). Classification was based on voxel-wise feature maps derived from structural MRI, ASL, and DTI. Support vector machines (SVMs) were trained to classify AD versus CN (AD-CN), FTD-CN, AD-FTD, and AD-FTD-CN (multi-class). Classification performance was assessed by the area under the receiver-operating-characteristic curve (AUC) and accuracy. Using SVM significance maps, we analysed contributions of brain regions.


Combining ASL and DTI with structural MRI resulted in higher classification performance for differential diagnosis of AD and FTD (AUC = 84%; p = 0.05) than using structural MRI by itself (AUC = 72%). The performance of ASL and DTI themselves did not improve over structural MRI. The classifications were driven by different brain regions for ASL and DTI than for structural MRI, suggesting complementary information.


ASL and DTI are promising additions to structural MRI for classification of early-onset AD, early-onset FTD, and controls, and may improve the computer-aided differential diagnosis on a single-subject level.

Key points

Multiparametric MRI is promising for computer-aided diagnosis of early-onset AD and FTD.

• Diagnosis is driven by different brain regions when using different MRI methods.

• Combining structural MRI, ASL, and DTI may improve differential diagnosis of dementia.


Classification Dementia Differential diagnosis Perfusion Diffusion tensor imaging 



Alzheimer’s disease


Arterial spin labelling


Area under the ROC curve


Cerebral blood flow


Cognitively normal controls


Diffusion tensor imaging


Fractional anisotropy


Frontotemporal dementia


Grey matter


Mini-Mental State Examination


Receiver-operating characteristic


Support vector machine


T1-weighted structural MRI


White matter


Voxel-based morphometry


Alzheimer's disease (AD) and frontotemporal dementia (FTD) are major diseases underlying dementia, especially in younger patients (age < 65 years) [1]. Establishing an accurate diagnosis in the early stage of the disease can be difficult. Although clinical symptomatology differs between the diseases, symptoms in the early stage may be unclear and can overlap [2, 3]. The current clinical criteria, which entail qualitative inspection of neuroimaging, fail to accurately differentiate AD from FTD [4]. However, early and accurate differential diagnosis of AD and FTD is very important, mainly because it gives patients access to supportive therapies [5, 6]. In addition, early diagnosis supports new research into understanding the disease process and developing new treatments [5, 6].

In this difficult case of differential diagnosis between AD and FTD, methods for computer-aided diagnosis may be beneficial. These methods make use of multivariate data analysis techniques that train a model (classifier) based on neuroimaging or related data, resulting in an objective diagnosis. In addition, computer-aided diagnosis can be more accurate than using only clinical criteria [7], as it potentially makes use of subtle group differences. Using structural T1-weighted (T1w) MRI to find characteristic patterns of brain atrophy, computer-aided diagnosis methods yielded accuracy of up to 84% for differentiation of AD and FTD [8, 9, 10].

Besides using structural MRI, evidence of neurodegeneration can be measured with advanced MRI techniques such as arterial spin labelling (ASL) and diffusion tensor imaging (DTI). ASL can non-invasively measure brain perfusion in terms of cerebral blood flow (CBF) [11, 12]. Recent studies have shown differences in perfusion patterns for FTD and AD indicating that this technique is promising for differential diagnosis [13, 14, 15, 16]. In addition, some classification studies showed an added value of ASL over atrophy measurements for AD diagnosis in individual patients, although others did not [13, 17, 18, 19]. Using DTI, the fractional anisotropy (FA) can be quantified, which is related to the degradation of white matter (WM) bundles. WM degradation has been shown to be more prominent in FTD than in AD, especially in frontal brain regions [14, 20, 21]. In classification studies, DTI generally shows a slight added value to atrophy measurements [22, 23, 24, 25, 26, 27, 28].

As ASL and DTI measure aspects of the neurodegenerative process that are different from brain volume changes, we hypothesise that these techniques have an added diagnostic value over structural MRI. Although ASL and DTI have been shown to be potential markers for differential diagnosis of AD and FTD, their combined added value for computer-aided differential diagnosis has not yet been evaluated. This study aims to investigate the added diagnostic value of ASL and DTI to structural MRI for classification of AD, FTD, and controls.

Materials and methods


We retrospectively included 24 AD patients, 33 FTD patients, and 34 cognitively normal (CN) controls. Patients who visited the memory clinic of our institution between February 2011 and June 2015 were considered for inclusion. Patients underwent neurological and neuropsychological examination as part of their diagnostic work-up. Patients with a Mini-Mental State Examination (MMSE) score ≥ 20 were included if they had undergone MR imaging with a standardised protocol including structural T1w MRI, ASL, and DTI. Patients with psychiatric or neurological disorders other than dementia were excluded. The reference standard was a diagnosis of AD or FTD established by consensus of a multidisciplinary team according to the clinical criteria [2, 3, 29]. Controls were recruited from patient peers and through advertisement, and had no memory complaints, history of neurological or psychiatric disease, or contra-indications for MRI.

This study was approved by the local medical ethics committee. Eighty-seven participants signed informed consent; consent from the remaining four patients was waived because of the retrospective nature of the study.

Image acquisition and processing

MR imaging was performed at 3 T with 8-channel head coils on two identical scanners (Discovery MR750; GE Healthcare, Milwaukee, WI, USA). The protocol included T1w, ASL, and DTI. High-resolution isotropic T1w images were acquired with 3D inversion recovery fast spoiled gradient-recalled echo. According to the recommendations for ASL [12], we acquired 3D pseudo-continuous ASL perfusion-weighted images and a separate proton-density image for scaling. DTI used 2D single-shot echo planar imaging in 25 non-collinear directions [30]. Detailed parameters are listed in Table 1.
Table 1

MRI acquisition parameters








2D single-shot EPI

Scan parameters (TI/TR/TE)

450 ms / 7.9 ms / 3.1 ms

1525 msa / 4632 ms / 10.5 ms

N.A. / 7925 ms / 82 ms


1 mm isotropic

3.3 mm isotropic

1.9 × 1.9 in-plane

Acquisition matrix

240 × 240 × 176

512 sampling points on 8 spirals

128 × 128

Reconstructed voxel size

0.9 × 0.9 × 1.0 mm (sagittal)

1.9 × 1.9 × 4.0 mm (axial)

0.9 × 0.9× 2.5 mm or 0.9 × 0.9 × 2.9 mm (axial)


 Labelling duration


1450 ms


 Number of excitations




 Background suppression






Interleaved fast spin echo



 Non-collinear directions




 Maximum b-value



1000 s/mm2

 No. b0 volumes (b-value = 0 s/mm2)




 Acquisition time

4:41 min

4:29 min

4:50 min

aFor ASL, TI equals the post-labelling delay

ASL arterial spin labelling, DTI diffusion tensor imaging, EPI echo-planar imaging, FSPGR fast spoiled gradient-recalled echo, IR inversion recovery, pCASL pseudo-continuous ASL, T1w structural T1-weighted MRI, TE echo time, TI inversion time, TR repetition time

For image processing, the Iris pipeline [19] was applied to obtain voxel-based measures of structural MRI, ASL, and DTI (see Appendix A for a detailed description). From structural MRI, we derived tissue segmentations—WM, grey matter (GM), cerebrospinal fluid—and a brain mask. In a group template space, we derived features based on voxel-based morphometry (VBM) within a mask of the 1) GM (VBM-GM), 2) WM (VBM-WM) and 3) supratentorial brain (VBM-Brain). For ASL, CBF was quantified using a single-compartment model and partial volume correction. The CBF voxel values of the GM in the template space were used as features for classification. For DTI, tensor fits were performed to derive FA maps. The FA voxel values in WM in the template space were used as features for classification.

Quality control

The following images were visually inspected (E.E.B., 5 years of experience): GM segmentation, WM segmentation, brain mask, template space registration, ASL registered to structural MRI, CBF map, DTI registered to structural MRI, and FA map. Any errors in the image processing were corrected until visual inspection revealed no more unacceptable results.

Analysis and statistics

Classifications of AD versus CN (AD-CN), FTD-CN, and AD-FTD were performed with linear support-vector-machine (SVM) classifiers [31]. The SVM C-parameter was optimised in cross-validation on the training set. Classifiers were trained on VBM-GM, VBM-WM, VBM-Brain, CBF, and FA features separately. For combination of multiple parameters, the classifiers were combined by averaging posterior probabilities [32]. The following multi-parametric classifiers were trained:
  • GM combination: VBM-GM and CBF

  • WM combination: VBM-WM and FA

  • Full combination: VBM-Brain, CBF, and FA

For multi-class classification (AD-FTD-CN), pairwise classifiers were combined by multiplying the posterior probabilities. Using fourfold cross-validation, the mean area under the receiver operating characteristic curve (AUC), the mean accuracy, and standard deviations over 50 iterations were computed. The multi-class AUC was evaluated over pairs of classes [33], and the multi-class accuracy equalled the correctly classified rate.

Differences in mean AUC and accuracy were tested: 1) CBF versus VBM-GM, 2) FA versus VBM-WM, 3) GM combination versus VBM-GM, 4) WM combination versus VBM-WM, 5) Full combination versus VBM-Brain. This was done using non-parametric permutation tests: the difference in performance of the two classifications was compared (α ≤ 0.05) to a null distribution that was estimated using 500 permutations in which the labels were randomly distributed over the samples.

For detection of features that contributed significantly to the SVM, we calculated statistical significance maps (p-maps). These maps were computed on all data using an analytical expression that approximates permutation testing [34]. Clusters of significant voxels were obtained by applying a slightly conservative p value threshold (α ≤ 0.01). We did not correct for multiple comparisons, as permutation testing has a low false-positive detection rate [35]. The clusters’ locations were identified by visual inspection.



The inclusion of participants is visualised in Fig. 1. Table 2 shows the demographics and MMSE scores of the participants (24 AD, 33 FTD, 34 CN). Four patients were excluded because of poor ASL data quality, i.e. motion artefacts or noise. Included FTD disease subtypes were as follows: behavioural variant FTD (bvFTD, n = 12), PPA (n = 16, including ten with semantic dementia [SD] and four with progressive non-fluent aphasia [PNFA]), and five patients with unknown subtype. In the AD group, six patients had <1 year follow-up (range 0–7 months), and the diagnosis of 18 patients was confirmed by >1 year follow-up (range 12–45 months). In the FTD group, 12 patients had <1 year follow-up (range 0–11 months), and 21 patients had >1 year follow-up (range 12–47 months).
Fig. 1

Flow of participants: a) patients with Alzheimer’s disease (AD), b) patients with frontotemporal dementia (FTD)

Table 2

Participant demographics

All participants








Age mean ± SD (range) [years]

67.1 ± 7.5 (52.4–81.3)

64.7 ± 8.8 (40.7–79.7)

64.7 ± 6.5 (46.5–78.8)

MMSE mean ± SD (range)b

24.1 ± 3.8 (15–30)a

25.3 ± 3.7 (15–30)a

28.7 ± 1.3 (25–30)









Age mean ± SD (range) [years]

67.3 ± 7.8 (52.4–81.3)

64.5 ± 8.2 (43.5–79.7)

66.6 ± 4.3 (58.1–78.8)

MMSE mean ± SD (range)b

24.1 ± 4.3 (15–29)a

25.1 ± 4.1 (15–30)a

28.4 ± 1.3 (25–30)









Age mean ± SD (range) [years]

66.9 ± 7.4 (60.8–79.4)

64.9 ± 9.6 (40.7–78.6)

61.4 ± 8.6 (46.5–75.5)

MMSE mean ± SD (range)b

24.2 ± 3.2 (20–30)

25.5 ± 3.4 (20–30)

29.3 ± 1.1 (27–30)

aTwo patients had MMSE scores of 15, which was due to language deficits. Their data were retained in the analysis, as their full neuropsychological examination indicated only moderate impairment in all cognitive domains except language

bThe maximum score for the Mini-Mental State Examination (MMSE) is 30

AD Alzheimer’s disease, CN cognitively normal controls, FTD frontotemporal dementia, MMSE Mini-mental state examination score

Classification results

Figure 2 shows the classification performance using T1w, ASL, and DTI voxel-wise features (Fig. 2a: AUC; 2b: accuracy). Table 3 shows non-parametric testing for significant differences between classifications.
Fig. 2

Area under the ROC curve (AUC) (a) and accuracy (b). The error bars show the standard deviation of 50 iterations of fourfold cross-validation. An asterisk (*) indicates a significant improvement over the classification using VBM features only (permutation test, p ≤ 0.05)

Table 3

P values of the non-parametric permutation tests to test statistical differences between classifiers based on a) mean area under the ROC curve (AUC) and b) mean accuracy




GM combination vs. VBM-GM

WM combination vs. VBM-WM

Full combination vs. VBM-Brain

a) Mean area under the ROC curve (AUC)

























b) Mean accuracy

























* Significant difference (p ≤ 0.05)

AD Alzheimer’s disease, AUC area under the receiver-operating characteristic curve, CBF cerebral blood flow, CN cognitively normal controls, FA fractional anisotropy, FTD frontotemporal dementia, GM grey matter, ROC receiver-operating characteristic, VBM voxel-based morphometry, WM white matter

For AD-CN classification, mean AUCs were 92% (VBM-GM), 87% (VBM-WM), 94% (VBM-Brain), 89% (CBF), 89% (FA), 95% (GM combination), 91% (WM combination), and 98% (Full combination). Classification accuracy was slightly lower than AUC in general. The performance using CBF and FA features was similar to that of the VBM features. The feature combinations yielded slightly higher performance than the VBM features, but differences were not significant.

For FTD-CN classification, AUCs using VBM were somewhat higher than for AD-CN, but combination with FA and CBF did not improve performance. AUCs were 95% (VBM-GM), 96% (VBM-WM), 95% (VBM-Brain), 87% (CBF), 91% (FA), 93% (GM combination), 95% (WM combination), and 96% (Full combination).

For differential diagnosis of AD versus FTD, AUCs were 78% (VBM-GM), 76% (VBM-WM), 72% (VBM-Brain), 81% (CBF), 80% (FA), 84% (GM combination), 81% (WM combination), and 84% (Full combination). Combination with CBF and FA features improved performance over the use of VBM features only.For multi-class diagnosis of AD, FTD, and CN, mean AUCs were 85% (VBM-GM), 83% (VBM-WM), 84% (VBM-Brain), 82% (CBF), 83% (FA), 87% (GM combination), 85% (WM combination), and 90% (Full combination). Classification accuracy was lower, but it should be noted that for this three-class diagnosis, the accuracy for random guessing would be only ~33%. For multi-class classification, AUCs were highest for the combination methods. The method that combined VBM-Brain with CBF and FA yielded a significantly higher AUC (90 vs. 84%, p = 0.03) and accuracy (75 vs. 70%, p = 0.05) than VBM-Brain by itself. This is reflected in the examples of confusion matrices for one iteration of the cross-validation (Appendix C; Table C1), which show a higher number of correctly classified patients and controls for Full combination than for VBM-Brain. However, combining VBM with ASL or DTI may also reduce the number of correctly classified patients, e.g. GM Combination has a lower number of correctly classified FTD patients than VBM-GM, while accuracy is improved.

Significance maps

Using SVM p-maps (Figs. 3, 4, and 5, Appendix B Figs. B1 and B2), we evaluated which voxels contributed significantly to the classifications. For VBM-GM (Fig. 3), we noted major influence of the perihippocampal region on the classifier; overall we observed a larger number of significant voxels in the left than in the right hemisphere. For differential diagnosis of AD-FTD, mainly voxels in the anterior temporal lobe were involved.
Fig. 3

SVM significance maps for voxel-based morphometry of the grey matter (VBM-GM): a) AD-CN, b) FTD-CN, c) AD-FTD. Colour overlay shows p values ≤ 0.01

Fig. 4

SVM significance maps for cerebral blood flow (CBF): a) AD-CN, b) FTD-CN, c) AD-FTD. Colour overlay shows p values ≤ 0.01

Fig. 5

SVM significance maps for fractional anisotropy (FA): a) AD-CN, b) FTD-CN, c) AD-FTD. Colour overlay shows p values ≤ 0.01

For VBM-WM (Fig. B1), we observed most clusters of significantly contributing voxels in the temporal lobe and around the ventricles. For AD-CN and FTD-CN classification, a smaller cluster of significant voxels in the corpus callosum was found. The temporal lobe clusters were present mainly in the left hemisphere, especially for AD-FTD differentiation.

For VBM-Brain (Fig. B2), p-maps were very smooth as the feature is formed by the Jacobian determinant of the spatially smooth deformation to template space. Smoothness is lost in VBM-GM and VBM-WM by multiplying the Jacobian determinant with the probabilistic tissue segmentations. For AD-CN, the classification was driven mainly by periventricular and left temporal lobe features. For FTD-CN, the temporal lobe contributed with the largest clusters of significant voxels. For AD-FTD, small clusters were found in the middle frontal gyrus, temporal lobe and periventricular regions.

For CBF (Fig. 4), p-maps showed small clusters of significant voxels in multiple brain regions. For AD-CN, significant voxels were observed mainly in the GM of the parietal lobe, precuneus, posterior cingulate gyrus, posterior temporal lobe and the insula. For FTD-CN, the main regions with significant voxels were the posterior cingulate gyrus, superior frontal gyrus, the straight gyrus, lingual gyrus and the putamen. For AD-FTD, the classification relied mainly on voxels from the posterior cingulate gyrus, parietal lobe, caudate nucleus, insula, temporal lobe and the cuneus.

For FA (Fig. 5), clusters of voxels in the corpus callosum and around the globus pallidus and putamen contributed significantly to the AD-CN classification. In addition, clusters of voxels in the visual and motor tracts contributed. For FTD-CN, the clusters of significant voxels were observed mainly in the anterior temporal lobe, the frontal WM, the corpus callosum, and language-associated tracts (uncinate fasciculus, superior longitudinal fasciculus). For the differential diagnosis of AD-FTD, fewer voxels were significant with only a cluster of significant voxels in the uncinate fasciculus.


Differential diagnosis of early-onset AD and FTD was improved (p = 0.03-0.05) by combining voxel-based features of ASL and DTI with those of structural MRI, however improvement was only borderline significant. For all classifications, ASL and DTI by themselves yielded performance similar to or slightly higher than structural MRI. While combining ASL and DTI with structural MRI improved differential diagnosis, no added value was observed for the classification of AD versus controls nor for the classification of FTD versus controls.

Classification performance was similar to that previously published on other data sets for pairwise differentiation of AD and FTD [8, 9], and slightly higher than that for multi-class classification [9]. The combination of ASL and DTI for classification of AD, FTD, and controls has not been assessed before, and therefore cannot be directly compared to literature results. The techniques have been applied separately to pairwise classifications. In concordance with our results, most studies using DTI obtained good classification performance [23, 24, 26, 27], but indicated no significant improvement over structural MRI [22, 25, 28]. In contrast to our current and previous work [19], most ASL-based classification studies showed a significant added value to structural MRI [13, 17, 18]. This is partly due to the higher performance of structural MRI in our studies. Additionally, not all studies avoid overestimation of classification performance by using cross-validation. For ASL, this overestimation might be larger than for structural MRI, because of lower signal-to-noise ratio and robustness. Conclusions obtained with or without cross-validation can therefore be expected to differ.

This work is, to the best of our knowledge, the first to perform multiparametric classification of structural MRI, ASL, and DTI. Multiparametric classification on other modalities has previously used feature-level combination (e.g. one large feature vector) or classifier-level combination (e.g. combining classifier posterior probabilities). In this study, we averaged posterior probabilities of the individual classifiers, since we had previously found this to outperform feature-level approaches [19].

The SVM significance maps showed that the brain regions contributing to the classifications corresponded to those associated with AD or FTD, which indicates that the classifier makes plausible decisions. For structural MRI, the temporal lobes showed large clusters of significant voxels. While the medial temporal lobe (i.e. hippocampus, amygdala) largely contributed to the classifications of AD versus controls and FTD versus controls, the differentiation between AD and FTD was based mainly on anterior temporal lobe features, which corresponds to the literature on atrophy in AD [27, 36, 37, 38, 39] and FTD [27, 39]. ASL and DTI showed less influence of the temporal lobe. In the frontal and language-associated regions, DTI contributed to the classifications involving FTD. While frontal atrophy is expected in FTD [27, 39], no frontal lobe contribution was observed. ASL p-maps showed significant areas in the parietal lobe for classifications involving AD [40]. While parietal lobe atrophy is often proposed as a differential marker [10, 27, 39], we did not find significant clusters in the VBM p-maps, which is in agreement with many VBM studies, e.g. [10, 41]. In addition to the parietal lobe, CBF in the cingulate gyri and subcortical structures—insula and caudate nucleus [40]—showed significant features for AD and FTD classification. Finally, DTI captured the contribution of the corpus callosum for all classifications [20, 21]. Since the clusters of voxels influencing the classifications showed different brain regions for ASL and DTI compared to structural MRI, neuropathological processes with a spatial distribution other than atrophy are likely to be depicted.

Both the improved performances for differential diagnosis and the involvement of different brain regions suggest that ASL and DTI have additional diagnostic value to structural MRI and could improve diagnosis of individual AD and FTD patients. However, suboptimal image quality of these techniques in general, e.g. low signal-to-noise ratio, may have limited their diagnostic power when used separately. Similar to our findings, studies using data from the Alzheimer's Disease Neuroimaging Initiative 2 (ADNI 2) have shown that ASL and DTI separately provide information that is not available on structural MRI, but do not show better diagnostic power [42].

A limitation of this study is that the diagnosis was based on clinical criteria rather than post mortem histopathological examination. Although diagnosis was typically confirmed by follow-up, it is possible that some of the patients were misdiagnosed. Additionally, the size of our data set (24 AD, 33 FTD, 34 controls) was modest albeit comparable to that of other studies. Studies performing classification of AD and FTD using structural MRI data are typically of similar size [9, 13] (only larger in [8]). To obtain these group sizes, we did not limit inclusion to young-onset dementia, but included five AD and six FTD patients who were older than 70 years. In young-onset dementia, computer-aided differential diagnosis of FTD and AD would be most clinically relevant, as these patients show larger overlap of symptoms [39]. Also, we pooled the patients of several FTD subgroups (bvFTD, SD, and PNFA), which could have influenced the classification results and the regions involved in classification. The modest data size did not allow for validation on a separate validation set; instead, cross-validation was used. In addition, potential vascular white matter damage in the AD group, e.g. infarcts and white matter hyperintensities, might have influenced the classification performance of DTI. However, we expect this effect to be small, as patients were excluded when they had a history of cerebrovascular accidents (CVA) or CVA reported in their MRI examination; additionally, they were relatively young.

Regarding these limitations and the results being only borderline significant, this study primarily has exploratory value. Future research on a larger and more specific presenile cohort is needed. To assess the generalisability of our conclusions, evaluation on multi-centre data and a separate validation set is necessary as well. With our current work, we presented a computer-aided diagnosis methodology based on structural MRI, ASL, and DTI which is ready to be evaluated on a larger data set when available.

In conclusion, we postulate that ASL and DTI are promising for multiparametric computer-aided diagnosis, since combining these techniques with structural MRI improved differentiation of early-onset AD and FTD in our study.



We would like to thank Inés Mérida and Sandrine Lacomme for their contributions to the early phase of this study. In addition, we acknowledge the European COST Action “Arterial spin labelling Initiative in Dementia (AID)” (BM1103).

The scientific guarantor of this publication is Esther E. Bron. W.J. Niessen declares relationships with the following companies: Quantib BV. Other authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study has received funding through an Erasmus MC grant on “Advanced MR neuroimaging in presenile dementia”. W.J. Niessen and S. Klein acknowledge funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 601055, VPH-DARE@IT.

E.E. Bron and S. Klein have significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was obtained from eighty-seven subjects (patients) in this study; consent from the remaining four patients was waived by the Institutional Review Board because of the retrospective nature of the study. Some study subjects or cohorts have been previously reported in [16] and [19]. First, we previously evaluated ASL for classification of dementia patients (n = 29) and controls (n = 29) on a subset of the data [19]. Second, we evaluated the diagnostic value of regional measures of ASL using a subset of 13 Alzheimer’s disease patients, 19 frontotemporal dementia patients, and 22 controls [16]. The current work extends this prior work to computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia, showing the added value of both ASL and DTI. Methodology: retrospective, diagnostic or prognostic study, performed at one institution.

Supplementary material

330_2016_4691_MOESM1_ESM.doc (34 kb)
ESM 1 (DOC 34.5 kb)
330_2016_4691_MOESM2_ESM.doc (24 kb)
ESM 2 (DOC 23 kb)
330_2016_4691_MOESM3_ESM.doc (60 kb)
ESM 3 (DOC 60 kb)
330_2016_4691_Fig6_ESM.gif (874 kb)

(GIF 874 kb)

330_2016_4691_MOESM4_ESM.eps (7.9 mb)
High resolution image (EPS 8115 kb)
330_2016_4691_Fig7_ESM.gif (774 kb)

(GIF 773 kb)

330_2016_4691_MOESM5_ESM.eps (7.7 mb)
High resolution image (EPS 7854 kb)


  1. 1.
    Alzheimer’s Association (2015) 2015 Alzheimer’s disease facts and figures. Alzheimers Dement 11:332–384CrossRefGoogle Scholar
  2. 2.
    McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456–2477CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Harris JM, Thompson JC, Gall C et al (2015) Do NIA-AA criteria distinguish Alzheimer’s disease from frontotemporal dementia? Alzheimers Dement 11:207–215CrossRefPubMedGoogle Scholar
  5. 5.
    Paquerault S (2012) Battle against Alzheimer’s disease: the scope and potential value of magnetic resonance imaging biomarkers. Acad Radiol 19:509–511CrossRefPubMedGoogle Scholar
  6. 6.
    Prince M, Bryce R, Ferri C (2011) World Alzheimer Report 2011, The benefits of early diagnosis and intervention. Alzheimer’s Disease InternationalGoogle Scholar
  7. 7.
    Klöppel S, Abdulkadir A, Jack CR et al (2012) Diagnostic neuroimaging across diseases. Neuroimage 61:457–463CrossRefPubMedGoogle Scholar
  8. 8.
    Möller C, Pijnenburg YAL, Tijms B, Hafkemeijer A (2016) Alzheimer disease and behavioral variant frontotemporal dementia: automatic classification based on cortical atrophy for single-subject diagnosis. Radiology 1–11Google Scholar
  9. 9.
    Raamana PR, Rosen H, Miller B et al (2014) Three-class differential diagnosis among Alzheimer disease, frontotemporal dementia, and controls. Front Neurol 5:1–15Google Scholar
  10. 10.
    Du A, Schuff N, Kramer J et al (2007) Different regional patterns of cortical thinning in Alzheimer’s disease and frontotemporal dementia. Brain 130:1159–1166CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Detre JA, Leigh JS, Williams DS, Koretsky AP (1992) Perfusion imaging. Magn Reson Med 23:37–45CrossRefPubMedGoogle Scholar
  12. 12.
    Alsop DC, Detre JA, Golay X et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73:102–116CrossRefPubMedGoogle Scholar
  13. 13.
    Du A, Jahng G, Hayasaka S, Kramer J (2006) Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 67:1215–1220CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Zhang Y, Schuff N, Ching C et al (2011) Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer’s disease and frontotemporal dementia. Int J Alzheimer Dis 2011:1–11CrossRefGoogle Scholar
  15. 15.
    Binnewijzend MA, Kuijer JPA, van der Flier WM et al (2014) Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 24:2326–2333CrossRefPubMedGoogle Scholar
  16. 16.
    Steketee RME, Bron EE, Meijboom R, Houston GC, Klein S, Mutsaerts HJMM et al (2016) Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI. Eur Radiol 26(1):244–253CrossRefPubMedGoogle Scholar
  17. 17.
    Dashjamts T, Yoshiura T, Hiwatashi A et al (2011) Simultaneous arterial spin labeling cerebral blood flow and morphological assessments for detection of Alzheimer’s Disease. Acad Radiol 18:1492–1499CrossRefPubMedGoogle Scholar
  18. 18.
    Mak HK-F, Qian W, Ng KS et al (2014) Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer’s disease from cognitively normal elderly adults. J Alzheimer Dis 41:749–758Google Scholar
  19. 19.
    Bron EE, Steketee RME, Houston GC, Oliver RA, Achterberg HC, Loog M et al (2014) Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia. Hum Brain Mapp 35(9):4916–4931CrossRefPubMedGoogle Scholar
  20. 20.
    Zhang Y, Schuff N, Du A-T et al (2009) White matter damage in frontotemporal dementia and Alzheimer’s disease measured by diffusion MRI. Brain 132:2579–2592CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Lu PH, Lee GJ, Shapira J et al (2014) Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer’s disease. J Alzheimer Dis 39:261–269Google Scholar
  22. 22.
    Friese U, Meindl T, Herpertz SC et al (2010) Diagnostic utility of novel MRI-based biomarkers for Alzheimer’s disease: diffusion tensor imaging and deformation-based morphometry. J Alzheimer Dis 20:477–490CrossRefGoogle Scholar
  23. 23.
    Haller S, Missonnier P, Herrmann FR et al (2013) Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. Am J Neuroradiol 34:283–291CrossRefPubMedGoogle Scholar
  24. 24.
    Besga A, Termenon M, Graña M et al (2012) Discovering Alzheimer’s disease and bipolar disorder white matter effects building computer aided diagnostic systems on brain diffusion tensor imaging features. Neurosci Lett 520:71–76CrossRefPubMedGoogle Scholar
  25. 25.
    Cui Y, Wen W, Lipnicki DM et al (2012) Automated detection of amnestic mild cognitive impairment in community-dwelling elderly adults: a combined spatial atrophy and white matter alteration approach. Neuroimage 59:1209–1217CrossRefPubMedGoogle Scholar
  26. 26.
    O’Dwyer L, Lamberton F, Bokde ALW et al (2012) Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PLoS One 7:e32441–e32441CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    McMillan CT, Avants BB, Cook P et al (2014) The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum Brain Mapp 35:4827–4840CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Dyrba M, Grothe M, Kirste T, Teipel SJ (2015) Multimodal analysis of functional and structural disconnection in Alzheimer’s disease using multiple kernel SVM. Hum Brain Mapp 36:2118–2131CrossRefPubMedGoogle Scholar
  29. 29.
    Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Jones DK, Leemans A (2011) Diffusion tensor imaging. Meth Molec Biol 711:127–144CrossRefGoogle Scholar
  31. 31.
    Chang C-C, Lin C-J (2011) LIBSVM: A library for support vector machines. ACM TIST 2:27–27Google Scholar
  32. 32.
    Tax DMJ, Van Breukelen M, Duin RPW, Kittler J (2000) Combining multiple classifiers by averaging or by multiplying? Pattern Recognit 33:1475–1485CrossRefGoogle Scholar
  33. 33.
    Hand DJ, Till RJ (2001) A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach Learn 45:171–186CrossRefGoogle Scholar
  34. 34.
    Gaonkar B, Shinohara RT, Davatzikos C (2015) Interpreting support vector machine models for multivariate group wise analysis in neuroimaging. Med Image Anal 24:190–204CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Gaonkar B, Davatzikos C (2013) Analytic estimation of statistical significance maps for support vector machine based multi-variate image analysis and classification. Neuroimage 78:270–283CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Bastos Leite A, Scheltens P, Barkhof F (2004) Pathological aging of the brain: an overview. Top Magn Reson Imaging 15:369–389CrossRefPubMedGoogle Scholar
  37. 37.
    Frisoni G, Testa C, Zorzan A et al (2002) Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 73:657–664CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Chételat G, Desgranges B, De La Sayette V et al (2002) Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 13:1939–1943CrossRefPubMedGoogle Scholar
  39. 39.
    Seelaar H, Rohrer JD, Pijnenburg YAL et al (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82:476–486CrossRefPubMedGoogle Scholar
  40. 40.
    Hu WT, Wang Z, Lee V-Y et al (2010) Distinct cerebral perfusion patterns in FTLD and AD. Neurology 75:881–888CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Whitwell JL, Josephs KA, Rossor MN et al (2005) Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 62:1402–1408CrossRefPubMedGoogle Scholar
  42. 42.
    Jack CR, Barnes J, Bernstein MA et al (2015) Magnetic resonance imaging in Alzheimer’s Disease Neuroimaging Initiative 2. Alzheimers Dement 11:740–756CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2016

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Esther E. Bron
    • 1
    Email author
  • Marion Smits
    • 2
  • Janne M. Papma
    • 3
  • Rebecca M. E. Steketee
    • 2
  • Rozanna Meijboom
    • 2
  • Marius de Groot
    • 1
    • 4
  • John C. van Swieten
    • 3
  • Wiro J. Niessen
    • 1
    • 5
  • Stefan Klein
    • 1
  1. 1.Biomedical Imaging Group Rotterdam, Departments of Medical Informatics and Radiology & Nuclear MedicineErasmus MCRotterdamThe Netherlands
  2. 2.Department of Radiology & Nuclear MedicineErasmus MCRotterdamThe Netherlands
  3. 3.Department of NeurologyErasmus MCRotterdamThe Netherlands
  4. 4.Department of EpidemiologyErasmus MCRotterdamThe Netherlands
  5. 5.Imaging Physics, Applied SciencesDelft University of TechnologyDelftThe Netherlands

Personalised recommendations